This content is restricted.
Brief
The inspection report highlights significant non-conformities and deficiencies in Curium Pet France's pharmaceutical establishment. The company failed to address critical issues, including inadequate deviation management, complaint handling, equipment qualifications, and maintenance. These shortcomings were documented in a letter sent on July 31, 2024, and the ANSM has issued an injunction, requiring Curium Pet France to rectify these issues within specific timeframes to ensure compliance with regulatory standards.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested